Xalud Therapeutics shifts focus to gene therapies for ALS treatment.
Xalud Therapeutics has shifted its focus to gene therapy, elevating a preclinical ALS program and putting its lead non-viral gene therapy on the partnering path, while letting go of employees, according to a former employee.